Analyst consensus rating

Niagen Bioscience Analyst Rating: Strong Buy

Direct answer

Niagen Bioscience's consensus rating is Strong Buy.

6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.67.
Forecast evidence checked November 18, 2026.

Get free Niagen Bioscience email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$2.04
Average price target
$10.67
High price target
$22.00
Low price target
$6.00
Low target gap
+194.1%
Target upside
+422.9%
High target gap
+978.4%
Target range width
784.3%
Consensus rating
Strong Buy
Analysts
6
Evidence date
November 18, 2026
Valid through
November 25, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Niagen Bioscience?

Niagen Bioscience has a verified Strong Buy consensus. The same dataset has an average price target of $10.67.

How far are Niagen Bioscience's low and high targets from the recorded price?

The low target implies +194.1%, while the high target implies +978.4%.

How many analysts are included in Niagen Bioscience's consensus?

The verified consensus includes 6 analysts.

How is Niagen Bioscience's target upside or downside calculated?

The average target of $10.67 is divided by the recorded price of $2.04, then one is subtracted to produce +422.9%. This does not guarantee a future return.

When was Niagen Bioscience's analyst forecast verified?

The data was verified on 2026-11-18. The dataset is valid through 2026-11-25.